TB Alliance Briefs Members of Congress on the Need for Greater U.S. Investment in TB Research
On October 8, 2009, the TB Alliance and Research!America co-sponsored a Capitol Hill Briefing in the US Senate chambers entitled,
News
News
New TB Alliance Publication Explores “What Countries Want” from New Regimens for Drug-Susceptible TB
Treatment shortening would be welcomed as a primary goal for future TB drug regimens, according to a new study from
News
TB Alliance Appoints Head of External Affairs
The TB Alliance recently announced the appointment of Marshall Burke, Ph.D. as the organization’s Senior Vice President, External Affairs. Dr.
News
Riminophenazine Project Reaches a Key Milestone
The Institute of Materia Medica (IMM), a member of the Chinese Academy of Sciences, was recently awarded a grant from
News
MDR-TB Headlines the 2009 Pacific Health Summit
Each year, the Pacific Health Summit convenes global thought leaders to better understand how to harness scientific advances to tackle
News
New development in TB treatment
Pharmaceutical giant Tibotec and the non-profit Global Alliance for TB Drug Development (TB Alliance) have teamed up to expedite the
News
TB Alliance, Tibotec, form partnership to take forward new drug
TB Alliance, Tibotec, form partnership to take forward new drug Keith Alcorn Wednesday, June 17, 2009 Aidsmap.com Tibotec announced today
News
J&J, nonprofit join to speed TB drug development
Healthcare company Johnson & Johnson (JNJ.N: Quote, Profile, Research, Stock Buzz) said on Wednesday it has joined with the nonprofit
News
Unique Collaboration Between TB Alliance And Tibotec to Accelerate Tuberculosis Drug Development
[Seattle, WA] A new landmark collaboration between the Global Alliance for TB Drug Development (TB Alliance) a not-for-profit, product development
News
J&J, Tibotec team with TB Alliance to develop and give access to tuberculosis drug
NEW YORK (AP) – Drug developer Johnson & Johnson said Wednesday it will work with the Global Alliance for TB